Statins represent a vital therapy for patients with dyslipidemia and for attenuating cardiovascular (CV) risk in both primary and secondary prevention.

Patients who received statin treatment demonstrated a 20% to 30% reduction in death and major cardiovascular events compared with patients who received placebo.

Atorvastatin

Class of medications: HMG-CoA reductase inhibitors (statins)

Atorvastatin Calcium

• Effectively decreases the coenzyme Q₁₀ level in the blood of the patients at risk for cardiovascular diseases and stroke.
• Reduces recurrent Ischemic events in patients with the acute coronary syndrome.
• Efficiently achieves Plasma LDL cholesterol reduction up to 61% in patients with high LDL count.